Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Epidemiology

Immunology

Pathology

Internal Medicine

Show all topics

DOI

10.1016/s0140-6736(18)31364-3

License

publisher-specific-oa